Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Anticoagulants acting via inhibition of thrombin designed at AstraZeneca

April 16, 2002

New BASF compounds for vitronectin-related disorders

April 10, 2002

FDA approves new indication for argatroban

April 10, 2002

Novel factor VIIa inhibitors reported in recent patent

April 8, 2002

AJW-200 exerts a sustained antiplatelet effect without excessive bleeding in primates

April 5, 2002

Shire files for European approval of Xagrid

April 3, 2002

Nycomed signs deal to become exclusive distributor of Angiomax in 35 countries

April 3, 2002

New class of TAFI inhibitors described by Pfizer particularly for promoting fibrinolysis

April 3, 2002

BB-10153 cleared to enter phase II trial

April 2, 2002

Triacetylshikimic acid: a potent and safe oral antiplatelet agent

April 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...